Posters

MaaT033 For Gut Microbiota Optimization To Improve Survival After Allogenic HCT: The PHOEBUS Trial

Date : February 26, 2026

Download the poster 📎

February 3, 2026: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

THRASSA, A Multicenter, Open-label Study Evaluating The Safety, Tolerability And Efficacy Of MaaT013 In Ruxolitinib-refractory Or Intolerant Paediatric/ Adolescent Participants With Gastrointestinal Acute Graft-versus-Host Disease